SCHEMBL335584

SCHEMBL335584

CCOC(=O)C(C)(CC=C(C)C)C(=O)OCC

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PKM P14618 3/20 0.43
MMP8 P22894 2/20 0.43
ALDH1A1 P00352 2/20 0.39
LMNA P02545 1/20 0.39
HSD17B10 Q99714 1/20 0.39
KDM4E B2RXH2 1/20 0.39
CYP4F2 P78329 3/20 0.38
CYP4A11 Q02928 3/20 0.38
THRB P10828 1/20 0.38
HTT P42858 1/20 0.37
GLO1 Q04760 1/20 0.35
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
MAPK1 P28482 1/20 0.35
MAPT P10636 1/20 0.34
ATM Q13315 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
ABCB11 O95342 1/20 0.34
CYP1A2 P05177 1/20 0.34
CYP3A4 P08684 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3737736 0.92 MMP8 (0.41) PKMMMP8ALDH1A1LMNAHSD17B10
SCHEMBL11136882 0.91 MMP8 (0.40) PKMMMP8ALDH1A1LMNAHSD17B10
SCHEMBL2438993 0.89 MMP8 (0.39) PKMMMP8ALDH1A1LMNAHSD17B10
SCHEMBL13287418 0.89 MMP8 (0.39) PKMMMP8ALDH1A1LMNAHSD17B10
SCHEMBL10836337 0.85 PKM (0.41) PKMMMP8ALDH1A1LMNAHSD17B10
SCHEMBL10836349 0.85 PKM (0.41) PKMMMP8ALDH1A1LMNAHSD17B10
SCHEMBL10836355 0.85 PKM (0.41) PKMMMP8ALDH1A1LMNAHSD17B10
SCHEMBL10655712 0.84 CYP4F2 (0.46) PKMMMP8ALDH1A1LMNAHSD17B10
SCHEMBL3743133 0.80 MEN1 (0.45) PKMMMP8KDM4ETHRBHTT
SCHEMBL14815133 0.79 ALOX15 (0.47) ALDH1A1KMT2AALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11028052-B2 Compounds useful as modulators of TRPM8 FIRMENICH INCORPORATED (US) 2021-06-08 US disclosed
EP-3461816-B1 FIVE-MEMBERED HETEROCYLIC COMPOUNDS USEFUL AS MODULATORS OF TRPM8 FIRMENICH INCORPORATED (US) 2021-03-24 EP disclosed
US-10421727-B2 Compounds useful as modulators of TRPM8 FIRMENICH INCORPORATED (US) 2019-09-24 US disclosed
EP-3461816-A1 FIVE-MEMBERED HETEROCYLIC COMPOUNDS USEFUL AS MODULATORS OF TRPM8 Senomyx, Inc. (US) 2019-04-03 EP disclosed
US-20170369447-A1 COMPOUNDS USEFUL AS MODULATORS OF TRPM8 FIRMENICH INCORPORATED 2017-12-28 US disclosed
US-9840471-B2 Compounds useful as modulators of TRPM8 SENOMYX, INC. (US) 2017-12-12 US disclosed
US-20150376136-A1 COMPOUNDS USEFUL AS MODULATORS OF TRPM8 SENOMYX, INC. 2015-12-31 US disclosed
EP-2958897-A2 COMPOUNDS USEFUL AS MODULATORS OF TRPM8 Senomyx, Inc. (US) 2015-12-30 EP disclosed
WO-2014130582-A2 COMPOUNDS USEFUL AS MODULATORS OF TRPM8 SENOMYX, INC. (US) 2014-08-28 WO disclosed
US-8222404-B2 [1,2,4]Thiadiazin-3-yl acetic acid compound and methods of making the acetic acid compound ANADYS PHARMACEUTICALS, INC. (US) 2012-07-17 US disclosed
US-20090306057-A1 [1,2,4]THIADIAZINE 1,1-DIOXIDE COMPOUNDS ANADYS PHARMACEUTICALS, INC. (US) 2009-12-10 US disclosed
US-20090306057-A1 [1,2,4]THIADIAZINE 1,1-DIOXIDE COMPOUNDS ANADYS PHARMACEUTICALS, INC. (US) 2009-12-10 US disclosed
US-20090306057-A1 [1,2,4]THIADIAZINE 1,1-DIOXIDE COMPOUNDS ANADYS PHARMACEUTICALS, INC. (US) 2009-12-10 US disclosed
US-4567195-A Azaprostacyclins, their preparation and pharmaceutical use SCHERING, AKTIENGESELLSCHAFT (DE) 1986-01-28 US disclosed
EP-0094951-B1 NEW PROSTACYCLINS AND PREPARATION METHOD THEREOF SCHERING AKTIENGESELLSCHAFT (DE) 1985-10-30 EP disclosed
US-4532236-A Certain prostacyclins and their blood-pressure-lowering and thrombocyte-aggregation-inhibiting compositions and methods SCHERING AKTIENGESELLSCHAFT (DE) 1985-07-30 US disclosed
US-4446147-A Azaprostacyclins, their preparation and pharmaceutical use SCHERING AKTIENGESELLSCHAFT (DE) 1984-05-01 US disclosed
EP-0058632-B1 (13E)-(8R,11R,12R)-11,15-DIHYDROXY-16,19-DIMETHYL-9-OXO-13,18-PROSTADIENOIC ACIDS AND THEIR SALTS, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS SCHERING AKTIENGESELLSCHAFT (DE) 1984-04-11 EP disclosed
EP-0094951-A1 NEW PROSTACYCLINS AND PREPARATION METHOD THEREOF. SCHERING AG (DE) 1983-11-30 EP disclosed
WO-1983001951-A1 NEW PROSTACYCLINS AND PREPARATION METHOD THEREOF NICKOLSON, ROBERT 1983-06-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10421727-B2 Compounds useful as modulators of TRPM8 TRPM8, TRPM7, TRPA1 PKM 1435/4885MMP8 1909/4885ALDH1A1 1692/4885
US-20150376136-A1 COMPOUNDS USEFUL AS MODULATORS OF TRPM8 TRPM8, TRPM7, TRPA1 PKM 1435/4885MMP8 1909/4885ALDH1A1 1692/4885
US-20170369447-A1 COMPOUNDS USEFUL AS MODULATORS OF TRPM8 TRPM8, TRPM7, TRPA1 PKM 1435/4885MMP8 1909/4885ALDH1A1 1692/4885
US-11028052-B2 Compounds useful as modulators of TRPM8 TRPM8, TRPM7, TRPA1 PKM 1435/4885MMP8 1909/4885ALDH1A1 1692/4885
US-20090306057-A1 [1,2,4]THIADIAZINE 1,1-DIOXIDE COMPOUNDS CYP2E1, CYP1A1, CYP1B1 PKM 4434/4885MMP8 4268/4885ALDH1A1 85/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.